Search

everythinglearnresearchcommunity

for

Search:↓

Male cells need DHT to respond to testosterone, while female cells do not.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Anabolic steroids and inflammation can disrupt androgen metabolism, potentially causing health issues.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

5α-reductase enzyme affects hormone levels, influencing conditions like acne and hair loss.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

Heart-specific steroid metabolism is crucial in cardiac hypertrophy.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Curcumin and its derivatives can block an enzyme important for making testosterone, with one derivative being particularly strong.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

Compound 4 is a promising treatment for hair loss with low toxicity.

The enzyme 25 Hydroxyvitamin D 1 α-Hydroxylase is essential for healthy skin and recovery after skin damage.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Human hair follicles can process steroid hormones like DHEA.

Women with acne have lower levels of a specific hormone marker than women without acne.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.